CLEVERCARDS
8.7.2021 17:32:08 CEST | Business Wire | Press release
Giuseppe Di Marco has joined CleverCards as Senior Vice President for Business Development Europe & Managing Director of CleverCards Italia, from Accel and Battery Ventures-backed, mid-market Spend Management leader, Soldo.
Di Marco led and built the Soldo business in Italy after a successful payments career as CEO of ePay Italy (Euronet: EEFT), CEO of the Zucchetti eCommerce and payments services division (Zucchetti is Italian market leader of ERP and HR software), Managing Director of Lottomatica Payments Services Division (LIS & Totobit Servizi) and Head of QuiGroup Payments Service Division.
CleverCards is a leading global payments platform which makes it possible for anyone, anywhere, anytime, to be paid instantly by enabling businesses, governments and public sector organisations to simply send a digital prepaid Mastercard to an email address or mobile phone number by SMS or WhatsApp, empowering the recipients to spend online, or use their mobile in-store contactlessly using Google Pay, Samsung Pay or Apple Pay immediately.
“The US and European B2B payment markets are highly fragmented and CleverCards is planning to consolidate it through an aggressive buy and build acquisition strategy, driving growth and expansion through digital transformation realising its vision of becoming the ubiquitous global payments platform”, says Kealan Lennon, Founder & CEO of CleverCards.
Earlier this year, CleverCards entered into a definitive agreement to acquire ExpendiaSmart®, a market leader in Europe for Spend Management Solutions and Smart Corporate Cards, along with a Licensed, Electronic Money Institution, subject to regulatory approval.
In February this year, Mastercard and CleverCards signed a strategic partnership and development agreement to expand the usage of digital cards across Europe, a FinTech partnership that provides unprecedented, unique access to Mastercard business development teams in key markets and to key commercial clients.
“Our B2B payments platform is growing exponentially, as organisations seek to manage employee, vendor and customer pay-outs on one platform. CleverCards needed someone with an intimate understanding of the payments industry and a demonstrable ability to rapidly scale a Fintech business. In Giuseppe we’ve found that. His track record speaks for itself and we’re very excited about CleverCards continued European expansion,” adds Lennon.
At CleverCards, Giuseppe will build upon the company’s reputation as a market leader in the corporate sector with Spend Management Solutions and Smart Corporate Cards for employees, drivers and contractors, into the Public Sector with digital Mastercards, empowering social welfare recipients to spend online, or use their mobile in-store contactlessly using Google Pay, Samsung Pay or Apple Pay.
Di Marco comments, “The future of payments is digital. While many companies are scrambling to offer individual B2B solutions, none enable large private or public sector organisations to manage employee, vendor, customer or public sector payments on one platform like CleverCards. We’re providing organisations with greater speed, control and flexibility on pay-outs than ever before. I think that’s a really exciting proposition and both organisations and cardholders love it!”
ENDS
ABOUT CLEVERCARDS
Public and private sector organisations of all sizes use the CleverCards payments platform, making it possible for anyone, anywhere, anytime to be paid instantly, regardless of where they are and without the need for a bank account. Empowered with effortless configuration, customised branding and personalisation, along with elegant mobile-first cardholder experiences, CleverCards uses technology to remove numerous unnecessary processes and participants from the payments value chain, delivering unrivalled efficiencies whilst automating the management of all relevant financial services regulations, including KYC and KYB onboarding, AML and PCI DSS compliance. Since launching its payments platform in December 2019, CleverCards has experienced dramatic growth, with over 5,000 large enterprise businesses and public sector organisations already using the platform. For more information visit www.clevercards.com
View source version on businesswire.com: https://www.businesswire.com/news/home/20210708005694/en/
Link:
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Imagine Dragons to Perform at Abu Dhabi Grand Prix21.5.2026 17:51:00 CEST | Press release
Ethara, organiser of the Formula 1 Etihad Airways Abu Dhabi Grand Prix, have announced that one of the world’s biggest bands, Imagine Dragons, will headline the Saturday After-Race Concerts at the F1 Season Finale in Abu Dhabi. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260521214839/en/ Imagine Dragons to perform at Formula 1 Etihad Airways Abu Dhabi Grand Prix (Photo: AETOSWire) The announcement is another landmark moment for the Abu Dhabi Grand Prix, whose thrilling Yasalam presented by e& fan entertainment offering has become synonymous with the F1 Championship finale in Abu Dhabi and is recognised as one of the most compelling sports and entertainment crossovers globally. The global chart-toppers join Lewis Capaldi and Zara Larsson, who are set to kick off a blockbuster line-up of performances on Yas Island on Thursday, 3 December, with more major international artists to be revealed. With their popular top hits, Ima
Carnegie Mellon University and Cleveland Clinic Develop AI System to Interpret Cardiac MRI Scans with Enhanced Accuracy21.5.2026 14:05:00 CEST | Press release
Trained on more than 13,000 patient studies, novel system significantly outperforms existing models by up to 35% A team of researchers from Carnegie Mellon University, in collaboration with Cleveland Clinic’s Cardiovascular Innovation Research Center, has developed an artificial intelligence (AI) system capable of interpreting some of the most complex heart scans in medicine, cardiac magnetic resonance imaging (MRI), without the need for manually labeled training data. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260521762286/en/ A team of researchers from Carnegie Mellon University, in collaboration with Cleveland Clinic’s Cardiovascular Innovation Research Center, has developed an artificial intelligence (AI) system capable of interpreting some of the most complex heart scans in medicine, cardiac magnetic resonance imaging (MRI), without the need for manually labeled training data. The novel system, called CMR-CLIP, is d
Otovo Hits 30,000 Customers in Under a Year, Tackling the Growing ‘Solar Service Crisis’21.5.2026 14:00:00 CEST | Press release
A growing wave of unsupported solar systems and rising electricity prices are creating strong demand for Otovo’s energy service platform Otovo ASA (“Otovo”), a leading global energy service provider for residential and commercial customers, today announced it has reached 30,000 customers across the U.S. and Europe. A total of 20,000 customers have enrolled in Otovo Care, the Company’s membership-based home and commercial energy service, which is powered by Otovo’s industry-leading AI platform, Endurance™. “Reaching 30,000 customers in less than year is proof positive that home and business owners value their power systems,” said William J. (John) Berger, CEO of Otovo. “The ‘solar service crisis’ that is leaving millions of orphaned energy systems without support is driving strong interest in our Otovo Care membership program. Every day your home or commercial power system is not working, you are throwing money away. Otovo’s rapid response service platform keeps you up and running, ensu
The Live Moment Effect: Genius Sports and MediaScience Study Finds Specific Moments in Live Sports Can Double Unaided Brand Recall21.5.2026 14:00:00 CEST | Press release
New research shows that brands aligned with emotionally heightened moments in live sports can improve ad effectiveness Genius Sports Limited (NYSE: GENI), a global leader in real-time sports data, today released new biometric research conducted with MediaScience showing that ads delivered immediately after emotionally heightened moments in live sports can double unaided brand recall. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260521475265/en/ The Live Moment Effect report from Genius Sports and MediaScience. The study, The Live Moment Effect, finds that advertising effectiveness is significantly influenced by a viewer’s emotional state immediately before an ad is shown. In controlled biometric testing, ads shown after high-intensity sporting moments, such as near-scoring plays or crucial momentum shifts, delivered approximately double the unaided brand recall of baseline conditions. The Moment Before the Ad Matters The r
Merck Announces First Patient Dosed in Phase 3 Study for Investigational Antibody-Drug Conjugate in Colorectal Cancer21.5.2026 14:00:00 CEST | Press release
Precemtabart tocentecan (Precem-TcT) is investigated as a potential first-in-class anti-CEACAM5 ADC, for the treatment of metastatic CRC (mCRC) CEACAM5 is overexpressed in the majority of colorectal tumors (~90%), and requires no patient selection Significant unmet need remains for clinically meaningful innovation in colorectal cancer (CRC), the second leading cause of cancer death worldwide Not intended for Canada-, UK- or US-based media Merck, a leading science and technology company, today announced that the first patient has been dosed in the Phase 3 PROCEADE®-CRC-03 trial (NCT07549412). The study is evaluating precemtabart tocentecan (Precem‑TcT), a potential first‑in‑class investigational anti‑CEACAM5 antibody‑drug conjugate (ADC), for the treatment of metastatic colorectal cancer (mCRC). “Leveraging our novel payload‑linker technology, Precem‑TcT is the first CEACAM5‑targeted ADC in clinical studies with an exatecan payload, rationally designed for stability and enhanced cancer
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom